<style type="text/css"> .wpb_animate_when_almost_visible { opacity: 1; }</style>
  • Using technology in tumor genomics to develop precision cancer therapeutics

    Investor Relations

Maxim Group Upgrades Trovagene from "Hold" to "Buy"

Revised model factoring in PCM-075 (AML drug) as the key driver of the company going forward - sets $4 target price.

Apr 13, 2017


PDF
email print rss pdf
3:34
3:34
Wistia video thumbnail - Susann-Berz Patient Video- Home Page

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

Cancel
message